494 related articles for article (PubMed ID: 28222149)
1. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B; Coulibaly JT; Hatz C; Keiser J
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial.
Coulibaly JT; Panic G; Silué KD; Kovač J; Hattendorf J; Keiser J
Lancet Glob Health; 2017 Jul; 5(7):e688-e698. PubMed ID: 28619227
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
9. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
10. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
11. Bayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'Ivoire.
Chammartin F; Houngbedji CA; Hürlimann E; Yapi RB; Silué KD; Soro G; Kouamé FN; N Goran EK; Utzinger J; Raso G; Vounatsou P
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3407. PubMed ID: 25522007
[TBL] [Abstract][Full Text] [Related]
12. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
Keiser J; Silué KD; Adiossan LK; N'Guessan NA; Monsan N; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2975. PubMed ID: 25033291
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
[TBL] [Abstract][Full Text] [Related]
15. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonography of ureteric abnormalities induced by Schistosoma haematobium infection before and after praziquantel treatment.
Kardorff R; Traoré M; Doehring-Schwerdtfeger E; Vester U; Ehrich JH
Br J Urol; 1994 Dec; 74(6):703-9. PubMed ID: 7827837
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
[TBL] [Abstract][Full Text] [Related]
18. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania.
Hatz CF; Vennervald BJ; Nkulila T; Vounatsou P; Kombe Y; Mayombana C; Mshinda H; Tanner M
Am J Trop Med Hyg; 1998 Nov; 59(5):775-81. PubMed ID: 9840596
[TBL] [Abstract][Full Text] [Related]
20. Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community.
Adewale B; Mafe MA; Sulyman MA; Idowu ET; Ajayi MB; Akande DO; Mckerrow JH; Balogun EO
Korean J Parasitol; 2018 Dec; 56(6):577-581. PubMed ID: 30630278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
